on Immunization Practices, which provides expert advice to the US Centers for Disease Control and Prevention and which are "often considered the standard of practice . . . around the globe." The report cited 30 instances in which its advisory statements "did not apply current standards of scientific rigor . . . and did not cite relevant work."
The report's lead author, Michael Osterholm, a former CDC consultant and an internationally recognized expert on flu, told the BMJ that a Dutch study cited by the CDC as evidence of vaccine efficacy was seriously flawed and constituted a "sales job." Nevertheless, Osterholm said, the current jab does offer some protection and should be used until a more effective vaccine can be developed.
Joseph Bresee, chief of the epidemiology and prevention branch in CDC's Influenza Division, told the BMJ, "I do not agree that CDC has inflated the benefits of influenza vaccine." He added that he agreed with Osterholm that until better vaccines were available the current ones should be recommended.
That recommendation, however, has come under fire from the authors of a Cochrane analysis that also found little to no benefit from flu vaccination.2 Tom Jefferson, lead author of several Cochrane reviews, told the BMJ, "Based on more than a decade of Cochrane reviews in adults, children, [the] elderly, and healthcare workers, there is no credible evidence that the inactivated vaccines have any effect other than saving on average half a working day in healthy adults and avoiding symptoms in those who least need it: healthy adults and adolescents. Depending on the season, you need to immunize 33 to 99 adults to avoid one set of symptoms."
Osterholm criticized the methods of the Cochrane analysis, saying that the reviewers' inclusion of studies that used serology titers rather than reverse transcription polymerase chain reaction or cultures to diagnose flu meant that its results were highly inaccurate.
However, he acknowledged that the direction of bias caused by use of serology titers would be to make a vaccine seem far more effective than it was, a surprising bias for a meta-analysis that found no benefit for flu vaccines. The Cochrane reviewers also stated in their meta-analysis that the studies reviewed were "at high risk of bias."
A growing number of healthcare facilities and states now require healthcare workers to be vaccinated against flu or face being fired or forced to wear masks and identification tags stating that they may be infectious. 
